VELA Investment Management LLC Acquires 108,435 Shares of Indivior PLC (NASDAQ:INDV)

VELA Investment Management LLC raised its position in Indivior PLC (NASDAQ:INDV - Free Report) by 722.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 123,435 shares of the company's stock after buying an additional 108,435 shares during the quarter. VELA Investment Management LLC owned about 0.09% of Indivior worth $1,212,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Toronto Dominion Bank lifted its position in shares of Indivior by 58.0% during the 1st quarter. Toronto Dominion Bank now owns 2,094,865 shares of the company's stock valued at $44,872,000 after acquiring an additional 769,000 shares during the period. Susquehanna International Group Ltd. purchased a new position in shares of Indivior in the 2nd quarter worth about $3,224,000. Millennium Management LLC lifted its holdings in Indivior by 48.1% during the second quarter. Millennium Management LLC now owns 493,313 shares of the company's stock valued at $7,952,000 after purchasing an additional 160,282 shares during the last quarter. Mediolanum International Funds Ltd purchased a new stake in Indivior during the third quarter valued at about $1,240,000. Finally, M&G Plc purchased a new stake in shares of Indivior in the first quarter worth about $2,518,000. 60.33% of the stock is owned by institutional investors.

Indivior Stock Performance

Shares of Indivior stock traded up $0.34 on Friday, reaching $9.35. The company's stock had a trading volume of 1,035,681 shares, compared to its average volume of 1,358,018. The company has a quick ratio of 0.65, a current ratio of 0.83 and a debt-to-equity ratio of 23.50. The stock has a 50-day moving average price of $9.81 and a 200-day moving average price of $13.39. Indivior PLC has a 52-week low of $7.33 and a 52-week high of $23.22.

Indivior (NASDAQ:INDV - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.15. The firm had revenue of $307.00 million for the quarter, compared to the consensus estimate of $302.25 million. Indivior had a negative return on equity of 351.08% and a negative net margin of 0.17%. As a group, sell-side analysts predict that Indivior PLC will post 1.66 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on INDV. Piper Sandler restated an "overweight" rating and issued a $16.00 target price (up previously from $15.00) on shares of Indivior in a report on Friday, October 25th. Craig Hallum dropped their price target on shares of Indivior from $20.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday, October 11th.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.